Cardiology

Quality improvement efforts may improve cath lab efficiencies

(HealthDay)—A quality improvement intervention can reduce inefficiencies in the cardiac catheterization lab, according to a study published online Jan. 31 in the Journal of the American College of Cardiology: Cardiovascular ...

Cardiology

Impaired survival with LVEF below 60 percent in aortic stenosis

(HealthDay)—For patients with severe aortic stenosis (AS), left ventricular ejection fraction (LVEF) below 60 percent is associated with impaired survival, according to a study published online Dec. 27 in JACC: Cardiovascular ...

Cardiology

CYP2C19-genotype guided antiplatelet tx may be beneficial

(HealthDay)—Patients with a CYP2C19 loss-of-function allele have increased risk of major adverse cardiovascular events (MACE) with clopidogrel versus alternative antiplatelet therapy after percutaneous coronary intervention ...

Cardiology

'09 to '15 saw increase in transradial access for STEMI PCI

(HealthDay)—Use of transradial access (TRA) for ST-elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI) increased from 2009 to 2015, with considerable geographic, operator, and institutional ...

Diseases, Conditions, Syndromes

'07 to '14 saw drop in proportion needing dialysis after TAVI

(HealthDay)—From 2007 to 2014 there was a decrease in the proportion of patients needing dialysis after transcatheter aortic valve implantation (TAVI), according to a study published online Aug. 2 in JACC: Cardiovascular ...

Cardiology

Embolic protection device useful post carotid artery stenting

(HealthDay)—For patients with carotid stenosis, use of an embolic protection device is associated with reduced risk for in-hospital stroke or death, major stroke or death, and stroke after carotid artery stenting, according ...

Cardiology

Ischemic outcomes don't vary with gender in ACS patients

(HealthDay)—For acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) and receiving clopidogrel, prasugrel, or ticagrelor, ischemic outcome does not differ by gender, according to a ...

page 5 from 16